Full Name
Christian Steidl
Job Title
Associate VP, Research
Company/Org.
BC Cancer
Speaker Bio
Dr. Steidl is the Research Director of the Centre for Lymphoid Cancer (CLC), Executive Director Research at BC Cancer, and Professor in the Department of Pathology and Laboratory Medicine at the University of British Columbia.
Dr. Steidl’s translational research group focuses on the pathogenesis of B cell lymphomas, tumor microenvironment biology, and applied genomics. He is most known for his discovery and characterization of novel gene mutations and microenvironment-related biomarkers in Hodgkin and Non-Hodgkin lymphomas.
The Steidl laboratory is fully equipped with next-generation sequencing instrumentation, including single-cell sequencing, exome, target capture, and whole genome sequencing, as well as a spatial transcriptomic platform and bioinformatics support. Additionally, Dr. Steidl has access to the BC Cancer Flow Cytometry Core, equipped with high-throughput flow analyzers.
As the Research Director of the CLC at BC Cancer, Dr. Steidl has access to a wide range of fully annotated clinical biospecimens banked in one of the largest population-based lymphoma biobanks in the world, enabling world-leading translational research in lymphoma.
Dr. Steidl is a member of the Scientific Advisory Board and Adolescents and Young Adults Lymphoma Steering Committee of the Lymphoma Research Foundation, past Chair of the American Society of Hematology Scientific Committee on Lymphoid Neoplasia, and Member of the Leukemia and Lymphoma Society of Canada Medical and Scientific Advisory Committee.
He was inducted as a member of the Royal Society of Canada, College for New Scholars, Artists and Scientists in 2017, and won an Allen Distinguished Investigator award in 2018.
Dr. Steidl’s translational research group focuses on the pathogenesis of B cell lymphomas, tumor microenvironment biology, and applied genomics. He is most known for his discovery and characterization of novel gene mutations and microenvironment-related biomarkers in Hodgkin and Non-Hodgkin lymphomas.
The Steidl laboratory is fully equipped with next-generation sequencing instrumentation, including single-cell sequencing, exome, target capture, and whole genome sequencing, as well as a spatial transcriptomic platform and bioinformatics support. Additionally, Dr. Steidl has access to the BC Cancer Flow Cytometry Core, equipped with high-throughput flow analyzers.
As the Research Director of the CLC at BC Cancer, Dr. Steidl has access to a wide range of fully annotated clinical biospecimens banked in one of the largest population-based lymphoma biobanks in the world, enabling world-leading translational research in lymphoma.
Dr. Steidl is a member of the Scientific Advisory Board and Adolescents and Young Adults Lymphoma Steering Committee of the Lymphoma Research Foundation, past Chair of the American Society of Hematology Scientific Committee on Lymphoid Neoplasia, and Member of the Leukemia and Lymphoma Society of Canada Medical and Scientific Advisory Committee.
He was inducted as a member of the Royal Society of Canada, College for New Scholars, Artists and Scientists in 2017, and won an Allen Distinguished Investigator award in 2018.
Speaking At
